Skip to content
Skip to navigation menu

English

RSS

Ymchwil

10 Ebr 2014

Developing new anti-cancer medicines

 Professor Chris McGuigan

The prospect of four new cancer medicines becoming a reality for patients has taken a huge step forward with the announcement of a £34M investment by a European private biotech company in University research.

ProTide is a platform developed by Professor Chris McGuigan and his team at Cardiff University’s School of Pharmacy and Pharmaceutical Sciences. ProTides are specifically designed to bypass key cancer cell resistance pathways that limit the efficacy of so many of today’s anti-cancer drugs.

Darllenwch mwy

First direct evidence of cosmic inflation First direct evidence of cosmic inflation

17/03/2014

Cardiff physicists part of international team

Lansio Cronfa Adeiladu Cymunedau GW4 Lansio Cronfa Adeiladu Cymunedau GW4

07/03/2014

Cronfa ymchwil GW4 i fynd i’r afael â ‘heriau mawr’ y byd

Ymchwil fyd-eang ar gyfer genynnau risg Alzheimer yn chwilio am gliwiau ymhlith dioddefwyr cynnar Ymchwil fyd-eang ar gyfer genynnau risg Alzheimer yn chwilio am gliwiau ymhlith dioddefwyr cynnar

21/02/2014

Y prosiect mwyaf o’i fath yn cael hwb ariannol o £388,000 gan Ymchwil Alzheimer y DU gyda chefnogaeth oddi wrth Iceland Foods

Mwy o Newyddion

The European Cancer Stem Cell Research Institute
Neuroscience & Mental Health Research Institute
Sustainable Places Research Institute
Cardiff Catalysis Insititute Advert
Cardiff University on Futurity